Pacific Exchange Trading Eight New Options

The Pacific Exchange (PCX) announced that today it began trading options on Abgenix, Inc. (ABGX/AZG); Angiotech Pharmaceuticals, Inc. (ANPI/AUJ); Consolidated Edison, Inc. (ED); Delphi Corp. (DPH/KHH/XOP); Hartford Financial Services, Inc./The (HIG/KAY/XZB); Lincoln National Corporation (LNC); Marvel Enterprises, Inc. (MVL) and Netscreen Technologies, Inc. (NSCN/QKN).

Abgenix options are trading on the January expiration cycle with exercise limits set at 75,000 contracts. The issue is being traded by lead market maker Catherine Clay of Timber Hill, LLC. Angiotech Pharmaceuticals options are trading on the March expiration cycle with exercise limits set at 13,500 contracts. The issue is being traded by lead market maker Catherine Clay of Timber Hill, LLC.

Consolidated Edison options are trading on the February expiration cycle with exercise limits set at 31,500 contracts. The issue is being traded by lead market maker Catherine Clay of Timber Hill, LLC.

Delphi options are trading on the March expiration cycle with exercise limits set at 75,000 contracts. The issue is being traded by lead market maker Catherine Clay of Timber Hill, LLC.

Hartford Financial Services options are trading on the March expiration cycle with exercise limits set at 75,000 contracts. The issue is being traded by lead market makers Ross Goodheart and Lee Gordon of Group One Trading.

Lincoln National options are trading on the January expiration cycle with exercise limits set at 60,000 contracts. The issue is being traded by lead market maker Catherine Clay of Timber Hill, LLC.

Marvel Enterprises options are trading on the March expiration cycle with exercise limits set at 31,500 contracts. The issue is being traded by lead market maker Catherine Clay of Timber Hill, LLC.

Netscreen Technologies options are trading on the March expiration cycle with exercise limits set at 75,000 contracts. The issue is being traded by lead market maker Catherine Clay of Timber Hill, LLC.